January 18 2010 11:32 PM EST
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
Scientists at the Gladstone Institute of Virology and Immunology have discovered an agent that might inhibit the infectivity of HIV. The agent, surfen, impairs the action of a factor in semen that greatly enhances the viral infection. Surfen might be used to supplement current HIV microbicides to greatly reduce HIV transmission during sexual contact.
The discovery was made by Nadia Roan, Ph.D., a senior fellow in the laboratory of GIVI director Warner Greene, MD, Ph.D.
Surfen is a small molecule that inhibits the actions of certain polysaccharide molecules called heparan sulfate proteoglycans, which are found on the surface of cells. Importantly for HIV infection, it also interferes with the action of semen-derived enhancer of viral infection. The discovery was published in the current issue of the Journal of Biological Chemistry.
"Surprisingly, although HIV readily replicates once inside the body, the virus struggles to establish a beachhead of infection during sexual transmission," says Greene, who is senior author of the study. "We have been studying SEVI, a naturally occurring factor present in semen that can make HIV thousands of times more infectious. Knowing more about surfen, a SEVI inhibitor, might enable us to lower transmission rates of HIV."
SEVI is a breakdown product of prostatic acid phosphatase, a common protein in semen. Under certain conditions, SEVI can increase HIV infectivity 100,000 times by facilitating the attachment of viruses to target cells. Because the majority of all HIV infections are thought to result from sexual contact (during which semen is either the vehicle carrying HIV or is present during the infection process), SEVI might have a significant impact on HIV transmission rates. Surfen interferes with the binding of SEVI to both target cells and HIV-1 virions but does not cause the SEVI fibrils to break up.
"Because SEVI can so greatly enhance HIV infectivity, supplementing current HIV microbicide candidates with SEVI inhibitors, such as surfen, might increase their potency and overall effectiveness," Greene explains.
From our Sponsors
Most Popular
“So much life to live”: Eric Nieves on thriving with HIV
September 03 2025 11:37 AM
The Talk: Beyond the exam room
August 13 2025 3:15 PM
Thanks to U=U, HIV-positive people can live long, happy, healthy lives
July 25 2025 2:37 PM
BREAKING: Supreme Court rules to save free access to preventive care, including PrEP
June 27 2025 10:32 AM
Messenger RNA could be the key to an HIV vaccine — but government cuts pose a threat
August 20 2025 8:02 AM
“I felt like a butterfly”: Niko Flowers on reclaiming life with HIV
July 23 2025 12:22 PM
Dancer. Healer. Survivor. DéShaun Armbrister is all of the above
July 02 2025 8:23 PM
The Talk: Starting the conversation
July 25 2025 4:47 PM
The lab coat just got queer
August 21 2025 10:00 AM
Plus: Featured Video
Latest Stories
HIV-positive men stage 'Kiss-In' protest at U.S.-Mexico border
December 01 2025 12:56 PM
What the AIDS crisis stole from Black gay men
December 01 2025 6:00 AM
Amazing People of 2025: Javier Muñoz
October 17 2025 7:35 PM
It’s National PrEP Day! Learn the latest about HIV prevention
October 10 2025 9:00 AM
“I am the steward of my ship”: John Gibson rewrites his HIV narrative
September 16 2025 2:56 PM
The Talk: Owning your voice
August 25 2025 8:16 PM
The Talk: Navigating your treatment
August 01 2025 6:02 PM
How the Black AIDS Institute continues to fill in the gaps
July 25 2025 1:06 PM
1985: the year the AIDS crisis finally broke through the silence
June 26 2025 11:24 AM
VIDEO: A man living with HIV discusses his journey to fatherhood
June 10 2025 4:58 PM
Trump admin guts $258 million in funding for HIV vaccine research
June 03 2025 3:47 PM
Grindr is reminding us why jockstraps are so sexy and iconic
May 02 2025 5:36 PM
HRC holds 'die-in' to protest Trump health care cuts
April 28 2025 2:11 PM
Two right-wing Supreme Court justices signal they may uphold access to PrEP and more
April 21 2025 4:10 PM
500,000 Children at Risk: PEPFAR Funding Crisis
April 08 2025 3:51 PM
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM







































































